These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26613731)

  • 1. Tumour budding in colorectal cancer: what do we know and what can we do?
    De Smedt L; Palmans S; Sagaert X
    Virchows Arch; 2016 Apr; 468(4):397-408. PubMed ID: 26613731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive power of tumour budding for lymph node metastasis in colorectal carcinomas: A retrospective study.
    Deb B; Jacob SE
    Indian J Med Res; 2019 Dec; 150(6):635-639. PubMed ID: 32048628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour budding at invasive margins and outcome in colorectal cancer.
    Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
    Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.
    Zlobec I; Lugli A
    Oncotarget; 2010 Nov; 1(7):651-61. PubMed ID: 21317460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching.
    De Smedt L; Palmans S; Andel D; Govaere O; Boeckx B; Smeets D; Galle E; Wouters J; Barras D; Suffiotti M; Dekervel J; Tousseyn T; De Hertogh G; Prenen H; Tejpar S; Lambrechts D; Sagaert X
    Br J Cancer; 2017 Jan; 116(1):58-65. PubMed ID: 27884016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor budding in colorectal cancer--ready for diagnostic practice?
    Koelzer VH; Zlobec I; Lugli A
    Hum Pathol; 2016 Jan; 47(1):4-19. PubMed ID: 26476568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour budding in colorectal carcinoma.
    Prall F
    Histopathology; 2007 Jan; 50(1):151-62. PubMed ID: 17204028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer.
    Rogers AC; Winter DC; Heeney A; Gibbons D; Lugli A; Puppa G; Sheahan K
    Br J Cancer; 2016 Sep; 115(7):831-40. PubMed ID: 27599041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour budding in solid cancers.
    Lugli A; Zlobec I; Berger MD; Kirsch R; Nagtegaal ID
    Nat Rev Clin Oncol; 2021 Feb; 18(2):101-115. PubMed ID: 32901132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumour-cell dissociation as a prognostic marker in colorectal cancer].
    Klarskov L; Engel UH; Mogensen AM; Jensen HL; Holck S
    Ugeskr Laeger; 2009 Sep; 171(39):2812-7. PubMed ID: 19811751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tumour budding in predicting survival in patients with primary operable colorectal cancer: a systematic review.
    van Wyk HC; Park J; Roxburgh C; Horgan P; Foulis A; McMillan DC
    Cancer Treat Rev; 2015 Feb; 41(2):151-9. PubMed ID: 25549950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour budding and its clinical implications in gastrointestinal cancers.
    Zlobec I; Berger MD; Lugli A
    Br J Cancer; 2020 Sep; 123(5):700-708. PubMed ID: 32601463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour budding - an additional prognostic factor in colorectal cancer survival.
    Kamall GH; Ulusoy C; Nikolovski A; Kamall S
    Pol J Pathol; 2023; 74(1):36-41. PubMed ID: 37306351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined epithelial marker analysis of tumour budding in stage II colorectal cancer.
    Slik K; Blom S; Turkki R; Välimäki K; Kurki S; Mustonen H; Haglund C; Carpén O; Kallioniemi O; Korkeila E; Sundström J; Pellinen T
    J Pathol Clin Res; 2019 Jan; 5(1):63-78. PubMed ID: 30358171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine kinase receptor B (TrkB) expression in colorectal cancers highlights anoikis resistance as a survival mechanism of tumour budding cells.
    Dawson H; Grundmann S; Koelzer VH; Galván JA; Kirsch R; Karamitopoulou E; Lugli A; Inderbitzin D; Zlobec I
    Histopathology; 2015 Apr; 66(5):715-25. PubMed ID: 25382057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour budding intensity in relation to cathepsin D expression and some clinicopathological features of colorectal cancer.
    Famulski W; Guzińska-Ustymowicz K; Sulkowska M; Chabowski A; Zalewski B; Piotrowski Z; Stasiak-Barmuta A; Sulkowski S
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():171-2. PubMed ID: 11820592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer.
    Zlobec I; Bihl MP; Foerster A; Rufle A; Lugli A
    Histopathology; 2012 Nov; 61(5):777-87. PubMed ID: 22803799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer.
    Rieger G; Koelzer VH; Dawson HE; Berger MD; Hädrich M; Inderbitzin D; Lugli A; Zlobec I
    Histopathology; 2017 Jun; 70(7):1044-1051. PubMed ID: 28061021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budding invasive margin and prognosis in colorectal cancer--no direct association with beta-catenin expression.
    Hörkkö TT; Klintrup K; Mäkinen JM; Näpänkangas JB; Tuominen HJ; Mäkelä J; Karttunen TJ; Mäkinen MJ
    Eur J Cancer; 2006 May; 42(7):964-71. PubMed ID: 16563744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
    Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
    Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.